Novo Nordisk Raises Forecasts on New Obesity Drug

Bloomberg Markets and Finance published this video item, entitled “Novo Nordisk Raises Forecasts on New Obesity Drug” – below is their description.

Aug.05 — Lars Fruergaard Jorgensen, Novo Nordisk chief executive officer, discusses first half earnings results. The Danish drug-maker raised its profit and sales forecasts for the year, reflecting high demand for its new obesity medication. He speaks with Bloomberg’s Dani Burger on “Bloomberg Surveillance: Early Edition”.

Bloomberg Markets and Finance YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

About This Source - Bloomberg Markets and Finance

Bloomberg Markets and Finance features news about financial markets from around the world. Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City. It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.

Bloomberg Books #Ad

Recent from Bloomberg Markets and Finance:

  • Oil Demand Is Rising With Worst of Pandemic Over, OPEC Chief Says
  • Deutsche Bank Americas CEO on Bringing Workers Back to Office
  • ‘Bloomberg Surveillance: Early Edition’ Full Show (0928/2021)
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.